Growing community of inventors

Strängnäs, Sweden

Per-Olov Eriksson

Average Co-Inventor Count = 3.43

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Per-Olov ErikssonErik Yngve Holmer (3 patents)Per-Olov ErikssonUlf Lindahl (2 patents)Per-Olov ErikssonHans-Peter Ekre (2 patents)Per-Olov ErikssonHans-Peter Ekre (2 patents)Per-Olov ErikssonErik Holmer (2 patents)Per-Olov ErikssonSven Oscarsson (1 patent)Per-Olov ErikssonKristofer Eriksson (1 patent)Per-Olov ErikssonMats Wahlgren (1 patent)Per-Olov ErikssonAnna Leitgeb (1 patent)Per-Olov ErikssonStefania Tiddia (1 patent)Per-Olov ErikssonLino Liverani (1 patent)Per-Olov ErikssonMats Wahlgren (1 patent)Per-Olov ErikssonStefania Tidia (1 patent)Per-Olov ErikssonStefania Tidia (0 patent)Per-Olov ErikssonPer-Olov Eriksson (3 patents)Erik Yngve HolmerErik Yngve Holmer (4 patents)Ulf LindahlUlf Lindahl (6 patents)Hans-Peter EkreHans-Peter Ekre (3 patents)Hans-Peter EkreHans-Peter Ekre (9 patents)Erik HolmerErik Holmer (5 patents)Sven OscarssonSven Oscarsson (2 patents)Kristofer ErikssonKristofer Eriksson (2 patents)Mats WahlgrenMats Wahlgren (3 patents)Anna LeitgebAnna Leitgeb (2 patents)Stefania TiddiaStefania Tiddia (1 patent)Lino LiveraniLino Liverani (1 patent)Mats WahlgrenMats Wahlgren (5 patents)Stefania TidiaStefania Tidia (4 patents)Stefania TidiaStefania Tidia (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Dilafor Ab (2 from 7 patents)

2. Dilaforette Ab (1 from 2 patents)

3. Lab-on-a-bead Ab (4 patents)

4. Modus Therapeutics Ab (0 patent)


3 patents:

1. 10023659 - Processes for the production of chemically-modified heparins

2. 9480701 - Low anticoagulant heparins

3. 9475888 - Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…